BXP vs STRO
Boston Properties Inc (BXP) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported BXP revenue for 2024-12-31 was $3.41B. Net income was $84.2M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. BXP currently screens at market cap $12.12B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
BXP currently screens at market cap $12.12B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the BXP and STRO stock pages for the full models.
Not investment advice.